Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adicet Bio, Inc. - Common Stock
(NQ:
ACET
)
0.9100
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Adicet Bio, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
June 27, 2023
Gainers
Via
Benzinga
Adicet Bio Stock Is Falling Premarket - Here's Why
June 27, 2023
Adicet Bio Inc (NASDAQ: ACET) shared safety and efficacy data from its Phase 1 study of ADI-001 for relapsed or refractory aggressive B-cell
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 27, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on Tuesday morning!
Via
InvestorPlace
MoonLake Immunotherapeutics, Applied Digital And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
June 27, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Adicet Bio's Cancer Candidate Shows Anti-Tumor Activity In Preclinical Study
May 18, 2023
Adicet Bio Inc (NASDAQ: ACET)
Via
Benzinga
Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
June 26, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
June 15, 2023
On Thursday, 64 companies achieved new lows for the year.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023
June 01, 2023
Via
Benzinga
Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference
June 01, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
May 18, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Present at the 2023 JMP Securities Life Sciences Conference
May 09, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Reports First Quarter 2023 Financial Results and Provides Business Updates
May 09, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 28, 2023
From
Adicet Bio, Inc.
Via
Business Wire
7 Biotech Stocks With Huge Return Potential for Long-Term Investors
April 26, 2023
Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers.
Via
InvestorPlace
Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference
April 13, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
March 15, 2023
From
Adicet Bio, Inc.
Via
Business Wire
7 Biotech Stocks That Could Be the Next Big Thing
March 15, 2023
Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough.
Via
InvestorPlace
Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit
March 09, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 28, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
February 15, 2023
On Wednesday, 35 stocks hit new 52-week lows.
Via
Benzinga
Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference
February 01, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 31, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
January 10, 2023
Tuesday's session saw 16 companies set new 52-week lows.
Via
Benzinga
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 30, 2022
From
Adicet Bio, Inc.
Via
Business Wire
Peering Into Adicet Bio's Recent Short Interest
December 13, 2022
Adicet Bio's (NASDAQ:ACET) short percent of float has risen 29.62% since its last report. The company recently reported that it has 4.02 million shares sold short, which is 12.56% of all regular shares...
Via
Benzinga
Dow Surges Over 250 Points; Weber Shares Spike Higher
December 12, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 250 points on Monday
Via
Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
December 12, 2022
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.